FDA late Wednesday announced emergency use authorizations for Abbott, Becton Dickinson and Quidel rapid COVID-19 antigen tests intended for serial screening of asymptomatic individuals multiple times on a routine basis.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,